Cowled Prue, Kanter Irene, Leonardos Lefta, Jackson Paul
Department of Surgery, The University of Adelaide, The Queen Elizabeth Hospital, Woodville, South Australia, Australia.
Neoplasia. 2005 Dec;7(12):1091-103. doi: 10.1593/neo.05364.
Uroplakin Ib is a structural protein on the surface of urothelial cells. Levels of uroplakin Ib mRNA are dramatically reduced or absent in many transitional cell carcinomas, but the molecular mechanisms responsible remain undetermined. Previously, we showed that loss of uroplakin Ib expression correlated with CpG methylation of Sp1/NFkappaB-binding motifs within the proximal promoter. In this study, we show that reporter activity was completely blocked by the methylation of three CpG pairs in this promoter region. Gel shift analysis using purified proteins or nuclear extracts showed that Sp1 and NFkappaB bound to motifs encompassing two of the three CpG pairs. Interestingly, the methylation of these two CpG sites did not prevent the binding of proteins to the promoter in gel shift analyses. Additionally, mutation of these two CpGs did not affect reporter activity, but mutation of 6-bp fragment spanning each CpG partially inhibited reporter activity, suggesting that these sites were functional. A requirement for both Sp1 and NFkappaB in regulating reporter activity was confirmed in transfection experiments using plasmids expressing individual proteins. Our data suggest that the methylation of specific CpG sites can silence the uroplakin Ib promoter, at least in part, by blocking the binding of Sp1 and NFkappaB, although other factors may be involved.
uroplakin Ib是尿路上皮细胞表面的一种结构蛋白。在许多移行细胞癌中,uroplakin Ib mRNA水平显著降低或缺失,但相关分子机制仍未明确。此前,我们发现uroplakin Ib表达缺失与近端启动子内Sp1/NFκB结合基序的CpG甲基化相关。在本研究中,我们发现该启动子区域中三个CpG对的甲基化完全阻断了报告基因活性。使用纯化蛋白或核提取物进行的凝胶迁移分析表明,Sp1和NFκB与包含三个CpG对中两个的基序结合。有趣的是,在凝胶迁移分析中,这两个CpG位点的甲基化并未阻止蛋白与启动子的结合。此外,这两个CpG的突变并不影响报告基因活性,但跨越每个CpG的6个碱基片段的突变部分抑制了报告基因活性,表明这些位点具有功能。在使用表达单个蛋白的质粒进行的转染实验中,证实了Sp1和NFκB在调节报告基因活性方面均有需求。我们的数据表明,特定CpG位点的甲基化至少部分通过阻断Sp1和NFκB的结合使uroplakin Ib启动子沉默,尽管可能涉及其他因素。